It was reported a decrease on HYPERTENSION DIAGNOSTICS INC (OTCMKTS:HDII)’s shares shorted with 76.77%. FINRA published shares shorted of HDII’s total 7,200 shares. The down change of 76.77% from 31,000 shares was reported.

HDII touched $0.0016 during the last trading session after $0.0002 change.Currently Hypertension Diagnostics, Inc. is after 0.00% change in last February 14, 2018. HDII has also shares volume. HDII by 0.00% the S&P500.

Hypertension Diagnostics, Inc. designs, develops, makes, and markets proprietary noninvasive medical devices that detect subtle changes in the elasticity of arteries in the United States and internationally.The firm is valued at $196,136. It offers CVProfilor, which allows a physician to non-invasively assess the elasticity of small and large arteries, of which small artery elasticity is the earliest and sensitive marker of cardiovascular disease.Last it reported negative earnings. The firm offers CVProfilor DO-2020, which provides a patient's arterial elasticity indices used in the assessment for underlying vascular disease; CVProfilor MD-3000 that offers a sensitive and specific guide to the presence of blood vessel disease; and HD/PulseWave CR-2000 research cardiovascular profiling system, which provides researchers and scientists with a non-invasive means to assess arterial elasticity in support of human research in various areas.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.